Conditions: Type 2 Diabetes Mellitus
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 36
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the safety, tolerability, and efficacy of LX4211 versus a placebo control in subjects with type 2 diabetes mellitus.

Detailed description:

Arms:
arm 1: A low dose of LX4211; daily oral intake for 28 days arm 2: A high dose of LX4211; daily oral intake for 28 days arm 3: Matching placebo dosing with daily oral intake for 28 days

Interventions: intervention 1: LX4211 Low Dose intervention 2: LX4211 High Dose intervention 3: Placebo
Intervention descriptions: intervention 1: A low dose of LX4211; daily oral intake for 28 days intervention 2: A high dose of LX4211; daily oral intake for 28 days intervention 3: Matching placebo dosing with daily oral intake for 28 days

Protocol document: